VEGFA c.385_386delinsGA ;(p.S129D)

Variant ID: 6-43738828-AG-GA

NM_003376.5(VEGFA):c.385_386delinsGA;(p.S129D)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases.

Translational Neurodegeneration
Xia, Xiaohuan X; Wang, Yi Y; Zheng, Jialin C JC
Publication Date: 2022-12-12

Variant appearance in text: VEGF: S129D
PubMed Link: 36510311
Variant Present in the following documents:
  • Main text
View BVdb publication page



Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles.

Aging And Disease
Jurgielewicz, Brian B; Stice, Steven S; Yao, Yao Y
Publication Date: 2021-09

Variant appearance in text: VEGF: S129D
PubMed Link: 34527423
Variant Present in the following documents:
  • Main text
  • ad-12-6-1476.pdf
View BVdb publication page



Exosomes as Novel Regulators of Adult Neurogenic Niches.

Frontiers In Cellular Neuroscience
Bátiz, Luis Federico LF; Castro, Maite A MA; Burgos, Patricia V PV; Velásquez, Zahady D ZD; Muñoz, Rosa I RI; Lafourcade, Carlos A CA; Troncoso-Escudero, Paulina P; Wyneken, Ursula U
Publication Date: 2015

Variant appearance in text: VEGF: S129D
PubMed Link: 26834560
Variant Present in the following documents:
  • Main text
  • fncel-09-00501.pdf
View BVdb publication page



Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.

Cell Death & Disease
Chatterjee, A A; Chatterjee, U U; Ghosh, M K MK
Publication Date: 2013-03-14

Variant appearance in text: VEGF: S129D
PubMed Link: 23492774
Variant Present in the following documents:
  • cddis201363x2.pdf
View BVdb publication page